The USPTO approved a patent for Axiogenesis AG for the invention of its in vitro assay to screen pharmaceutical drug candidates for effectiveness and safety in treating Hypertrophic Cardiomyopathy .
http://www.businesswire.com/news/topix/20121204005099/en
http://www.businesswire.com/news/topix/20121204005099/en
No comments:
Post a Comment